PTAB to Review Two Eylea® (aflibercept) Patents After Granting Mylan's Challenges | Rothwell, Figg, Ernst & Manbeck, P.C.
The U.S. Patent and Trademark Office (USPTO) recently instituted two of Mylan’s petitions seeking Inter Partes Review of Regeneron’s U.S. Patent No. 9,669,069 B2 (the “’069 Patent,”...